Digital Health in Pharma News
VRVIRUS Shutterstock
Recipharm launches platform for Quality by Design
Recipharm announced the launch of ReciPredict, a platform for Quality by Design (QbD), designed to transform the landscape of drug product development, tech transfer and manufacturing. Read more
18 Sep 2024
Alones Shutterstock
Envision Pharma Group launches EnvisionOne Insights
Envision Pharma Group has launched its new data and analytics management solution, EnvisionOne Insights. Read more
16 Sep 2024
Okrasiuk Shutterstock
Bayer launches new healthy-ageing ecosystem for consumers
Bayer is taking a step in the emerging healthy-ageing space by offering consumers new tools to help them support their healthy-ageing journey with its new Age Factor ecosystem. Read more
10 Sep 2024
Newcells Biotech
Newcells Biotech launches Lung Ciliary Beat Frequency assay
Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has announced the launch of its proprietary CiliaBeat software. Read more
9 Sep 2024
Medidata
Eisai selects Medidata's Clinical Data Studio to enhance clinical trial efficiency and patient experience
Medidata has announced Eisai Inc, the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven Medidata Clinical Data Studio. Read more
5 Aug 2024
fizkes / Shutterstock.com
Otsuka and Oxford HIN collaborate to gather insights into digital therapeutics for mental health
Otsuka Pharmaceuticals is collaborating with Health Innovation Oxford HIN to evaluate the implementation and integration of a new digital therapeutic (DTx), CARE for MDD, intended to support the treatment of major depressive disorder (MDD). Read more
29 Jul 2024
Stock-Asso Shutterstock
The Practical Impact of Generative AI in Life Science Manufacturing
Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability. Read more
16 Jul 2024
Shutterstock
AI for Pharma Companies: The Role of Legal Departments
Jerry Temko, Managing Director, In-House Counsel Group, Major, Lindsey & Africa explores how Life science companies are becoming more alive to the role that in-house legal teams will play in safely and successfully taking on the AI challenge. Read more
22 Sep 2023
Future Pharma: How digital transformation will revolutionise our time-to-market
Developing new drugs is expensive and time-consuming, yet, digital manufacturing techniques are delivering significant benefits without compromising on quality, as Eric Flynn, Head of Pharmaceuticals and Life Sciences at Siemens GB&I explains. Read more
22 Jun 2023
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
Dar1930/Adobe Stock
Terumo automates manufacturing to expand cell & gene therapies
Terumo advances adoption of automated manufacturing to bring novel cell and gene therapies to more Latin American patients. Read more
29 Oct 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Discovery Park
Logical Biological expands at Discovery Park after trade growth
Logical Biological has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus. Read more
29 Oct 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Naobios
Naobios and Sumagen optimise HIV vaccine candidate for scale-up
Naobios and Sumagen Canada Inc, a Korean-Canadian biotechnology company developing an HIV-1 vaccine candidate, announced the production of the HIV-1 vaccine candidate at bench scale. Read more
29 Oct 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Papisut/Adobe Stock
AstraZeneca drug approved in the EU for rare immune disease
AstraZeneca’s drug Fasenra (benralizumab) has been approved in the European Union as an additional treatment for adults with eosinophilic granulomatosis with polyangiitis (EGPA). Read more
28 Oct 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
CluePoints
CluePoints appoints Richard Young as chief strategy officer
CluePoints announced that Richard Young has been appointed as its new chief strategy officer who will ensure CluePoints’ continued growth and development as a provider of integrated data review software. Read more
28 Oct 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Tahir AI/Adobe Stock
Takeda presents positive proof-of-concept results for IgAN patients
Takeda announced positive interim results from a Phase 3-enabling proof-of-concept study for mezagitamab (TAK-079), an anti-CD83 monoclonal antibody, in patients with primary immunoglobulin A nephropathy (IgAN). Read more
28 Oct 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
